The mechanism by which pentosan polysulfate sodium achieves its effects in patients is unknown. In preliminary clinical models, pentosan polysulfate sodium showed its activity by adhering to the bladder wall mucosal membrane and forming a layer of GAG. The drug may act as a buffer to control cell permeability preventing irritating solutes in the urine from reaching the cells.